Abstract:AIMTo assess the prognostic value of serum human relaxin 2 (H2 RLN) level in patients with esophageal squamous cell carcinoma (ESCC).METHODSFrom October 1998 to September 2009, 146 patients with histopathologically confirmed ESCC were enrolled in this study. One hundred patients underwent en bloc esophagectomy, and 46 patients with unresectable tumors underwent palliative surgery. Five of the 146 patients died of surgical complications. Serum levels of H2 RLN were measured by enzyme linked immunosorbent assay. The relationship between serum H2 RLN level and each of the clinicopathological parameters was analyzed using the χ² test. Patients were classified into two groups according to their H2 RLN level (< 0.462 ng/mL vs ≥ 0.462 ng/mL). When any analysis cell had fewer than five cases, the Fisher's exact test was used. The statistical difference between groups A and B in each clinicopathological category was determined by the Student's t test (two-tailed) or analysis of variance. Survival curves were plotted using the Kaplan-Meier method. The statistical difference in survival between the different groups was compared using the log-rank test. Survival correlation with the prognostic factors was further investigated by multivariate analysis using the Cox proportional hazards model with backward stepwise likelihood ratio.RESULTSESCC patients tended to have significantly higher serum H2 RLN concentrations (0.48 ± 0.17 ng/mL, n = 141) compared with the healthy control group (0.342 ± 0.12 ng/mL, n = 112). There was a significant difference between patients with lymph node involvement (0.74 ± 0.15 ng/mL, n = 90), distant metastasis (0.90 ± 0.19 ng/mL, n = 32) and those without lymph node involvement (0.45 ± 0.12 ng/mL, n = 51), and distant metastasis (0.43 ± 0.14 ng/mL, n = 109), respectively (P < 0.01). Patients with high H2 RLN levels (≥ 0.462 ng/mL) had a poorer prognosis than patients with low serum H2 RLN levels (< 0.462 ng/mL; P = 0.0056). The H2 RLN level was also correlated with survival and tumor-node-metastasis staging, but not with age, tumor size, gender, lymphovascular invasion or the histological grade of tumors. Cox regression analysis showed that H2 RLN was an independent variable.CONCLUSIONSerum concentrations of H2 RLN are frequently elevated in ESCC patients and are correlated with disease metastasis and survival. Serum concentrations of H2 RLN may be an important prognostic marker in ESCC patients.

Elevated levels of serum nidogen-2 in esophageal squamous cell carcinoma

Metastasis-suppressing NID2, an epigenetically-silenced gene, in the pathogenesis of nasopharyngeal carcinoma and esophageal squamous cell carcinoma

Elevated serum eotaxin and IP‐10 levels as potential biomarkers for the detection of esophageal squamous cell carcinoma

Elevated Serum Levels of Human Relaxin-2 in Patients with Esophageal Squamous Cell Carcinoma

The prognostic value of serum neuron specific enolase detection in small cell lung cancer

Notch2 As a Promising Prognostic Biomarker for Oesophageal Squamous Cell Carcinoma

Diagnostic and Prognostic Value of Serum Angiopoietin-Like Protein 2 in Patients with Non-Small Cell Lung Cancer

[Dysregulation of Annexin II Expression in Esophageal Squamous Cell Cancer and Adjacent Tissues from a High-Incidence Area for Esophageal Cancer in Henan Province].

Role of Nidogen-2 in diagnosis and prognosis of head and neck squamous cell carcinoma: A systematic review

Evaluation of Serum Nidogen-2 as a Screening and Diagnostic Tool for Ovarian Cancer

Nidogen-2: A new biomarker in colon cancer patients

Discovery and Validation of Combined Biomarkers for the Diagnosis of Esophageal Intraepithelial Neoplasia and Esophageal Squamous Cell Carcinoma

Study on Serum Vascular Endothelial Growth Factor-C Level in Patients with Primary Human Esophageal Squamous Cell Carcinomas-A Possible Marker of Lymph Node Metastasis

The Clinical Significance of Isocitrate Dehydrogenase 2 in Esophageal Squamous Cell Carcinoma.

Serum spleen tyrosine kinase and vascular endothelial growth factor-C levels predict lymph node metastasis of oesophageal squamous cell carcinoma

Overexpression of serum HMGB1 and IDO in esophageal squamous cell carcinoma patients: potential clinical auxiliary diagnostic markers and immunotherapeutic targets

Pretreatment NRS-2002 scores combined with hematologic inflammation markers are independent prognostic factors in patients with resectable thoracic esophageal squamous cell carcinoma.

Serum Her 2 Extracellular Domain Level Is Correlated With Tissue Her 2 Status In Metastatic Gastric Or Gastro-Oesophageal Junction Adenocarcinoma

Prognostic Role of Neutrophil-Lymphocyte Ratio in Operable Esophageal Squamous Cell Carcinoma

Secreted proteins encoded by super enhancer-driven genes could be promising biomarkers for early detection of esophageal squamous cell carcinoma

Elevated Serum Synuclein-Gamma in Patients with Gastrointestinal and Esophageal Carcinomas